[HTML][HTML] Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target
V Infantino, A Santarsiero, P Convertini… - International journal of …, 2021 - mdpi.com
In order to meet the high energy demand, a metabolic reprogramming occurs in cancer cells.
Its role is crucial in promoting tumor survival. Among the substrates in demand, oxygen is …
Its role is crucial in promoting tumor survival. Among the substrates in demand, oxygen is …
Up-down regulation of HIF-1α in cancer progression
M Rashid, LR Zadeh, B Baradaran, O Molavi… - Gene, 2021 - Elsevier
Hypoxia induicible factor-1 alpha (HIF-1α) is a key transcription factor in cancer progression
and target therapy in cancer. HIF-1α acts differently depending on presence or absence of …
and target therapy in cancer. HIF-1α acts differently depending on presence or absence of …
Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential
Background Vanillic acid is a phenolic compound, found in various dietary sources and
medicinal plants. Apart from its extraction from these biological sources, it is also …
medicinal plants. Apart from its extraction from these biological sources, it is also …
Revisiting the HIF switch in the tumor and its immune microenvironment
SJ Cowman, MY Koh - Trends in cancer, 2022 - cell.com
Hypoxia is a hallmark of all solid tumors and their metastases. This leads to activation of the
hypoxia-inducible factor (HIF) family of transcription factors, which modulate gene …
hypoxia-inducible factor (HIF) family of transcription factors, which modulate gene …
[HTML][HTML] HIF-1α pathway: role, regulation and intervention for cancer therapy
GN Masoud, W Li - Acta Pharmaceutica Sinica B, 2015 - Elsevier
Abstract Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer
drug target. Many recent studies have provided convincing evidences of strong correlation …
drug target. Many recent studies have provided convincing evidences of strong correlation …
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
GL Semenza - Trends in pharmacological sciences, 2012 - cell.com
Hypoxia-inducible factors (HIFs) mediate adaptive physiological responses to hypoxia. In
human cancers that are accessible for O 2 electrode measurements, intratumoral hypoxia is …
human cancers that are accessible for O 2 electrode measurements, intratumoral hypoxia is …
Autophagy in the physiological endometrium and cancer
L Devis-Jauregui, N Eritja, ML Davis, X Matias-Guiu… - Autophagy, 2021 - Taylor & Francis
Autophagy is a highly conserved catabolic process and a major cellular pathway for the
degradation of long-lived proteins and cytoplasmic organelles. An increasing body of …
degradation of long-lived proteins and cytoplasmic organelles. An increasing body of …
[PDF][PDF] The PI3K/AKT pathway in the pathogenesis of prostate cancer
H Chen, L Zhou, X Wu, R Li, J Wen… - … Biosci (Landmark Ed), 2016 - article.imrpress.com
Despite recent advances in our understanding of the biological behavior of prostate cancer
(PCa), PCa is becoming the most common malignancy in men worldwide. The …
(PCa), PCa is becoming the most common malignancy in men worldwide. The …
Hypoxia inducible factor as a therapeutic target for atherosclerosis
T Jain, EA Nikolopoulou, Q Xu, A Qu - Pharmacology & therapeutics, 2018 - Elsevier
Atherosclerosis is a highly prevalent disease that can significantly increase the risk of major
vascular events, such as myocardial or cerebral infarctions. The anoxemia theory states that …
vascular events, such as myocardial or cerebral infarctions. The anoxemia theory states that …
Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐and metastasis‐initiating cells
M Mimeault, SK Batra - Journal of cellular and molecular …, 2013 - Wiley Online Library
Accumulating lines of experimental evidence have revealed that hypoxia‐inducible factors,
HIF‐1α and HIF‐2α, are key regulators of the adaptation of cancer‐and metastasis‐initiating …
HIF‐1α and HIF‐2α, are key regulators of the adaptation of cancer‐and metastasis‐initiating …